Cadre price target raised to $45 from $38 at BofA

BofA analyst Ronald Epstein raised the firm’s price target on Cadre to $45 from $38 and keeps a Buy rating on the shares, noting that the company closed two deals – Icor Robotics and Alpha Safety – in January as Cadre “continues its pac-man like journey of acquiring niche safety focused suppliers.” The firm says its increased price target takes into account inorganic growth from Icor and Alpha Safety and the company’s ability to execute more deals in the near term.